Contact this trialFirst, we need to learn more about you.
Calcium Channel Blocker
Atogepant vs Topiramate for Migraine
Recruiting1 awardPhase 3
Victoria, British Columbia
This trial will study whether a medicine (atogepant) is safe and effective for preventing migraine symptoms compared to another medicine (topiramate). 520 participants will be enrolled worldwide. Both medicines are taken by mouth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service